Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels
{{output}}
Background: The U.S. Food and Drug Administration identifies abstinence and the absence of heavy drinking days as outcomes for pharmacotherapy trials for alcohol use disorder (AUD). However, many individuals with AUD struggle to ... ...
